-
141
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: “…Advanced non-small cell lung cancer…”
Get full text
Article -
142
Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational stud...
Published 2025-02-01Subjects: “…RET fusion-positive non-small cell lung cancer…”
Get full text
Article -
143
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
Published 2025-01-01Subjects: Get full text
Article -
144
Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
Published 2024-12-01Subjects: “…extensive‐stage small cell lung cancer…”
Get full text
Article -
145
-
146
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
Published 2025-01-01Subjects: “…Non-Small Cell Lung Cancer…”
Get full text
Article -
147
Presence of liver metastasis correlated with high tumor abundance and indicated adverse prognostic feature in EGFR mutation non-small-cell lung cancer patients
Published 2025-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
148
High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
Published 2025-01-01Subjects: Get full text
Article -
149
Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-...
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
150
-
151
Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
152
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer
Published 2025-02-01Subjects: Get full text
Article -
153
-
154
[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
155
Updated Bayesian network meta-analysis on the efficacy and safety of PD−1 versus PD−L1 inhibitors in first−line treatment with chemotherapy for extensive−stage small-cell lung canc...
Published 2025-01-01Subjects: “…extensive-stage small-cell lung cancer…”
Get full text
Article -
156
A novel sensitizer reduces EGFR-TKI resistance by regulating the PI3K/Akt/mTOR pathway and autophagy
Published 2025-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
157
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
Published 2025-01-01Subjects: “…Non–small cell lung cancer…”
Get full text
Article -
158
Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
Published 2025-01-01Subjects: Get full text
Article -
159
Intervening Non-Small-Cell Lung Cancer Progression by Cell Membrane Coated Platycodin D via Regulating Hsa-miR-1246/FUT9/GSK3β Pathway
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
160
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis
Published 2025-02-01Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text
Article